“Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY”. 2026. Frontier in Medical and Health Research 4 (3): 4636-45. https://fmhr.net/index.php/fmhr/article/view/3855.